PL372202A1 - Zmodyfikowana briodyna 1 o obniżonej immunogeniczności - Google Patents

Zmodyfikowana briodyna 1 o obniżonej immunogeniczności

Info

Publication number
PL372202A1
PL372202A1 PL03372202A PL37220203A PL372202A1 PL 372202 A1 PL372202 A1 PL 372202A1 PL 03372202 A PL03372202 A PL 03372202A PL 37220203 A PL37220203 A PL 37220203A PL 372202 A1 PL372202 A1 PL 372202A1
Authority
PL
Poland
Prior art keywords
byrodin
modified
reduced immunogenicity
immunogenicity
reduced
Prior art date
Application number
PL03372202A
Other languages
English (en)
Inventor
Matthew Baker
Francis J. Carr
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL372202A1 publication Critical patent/PL372202A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL03372202A 2002-06-11 2003-06-10 Zmodyfikowana briodyna 1 o obniżonej immunogeniczności PL372202A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02012911 2002-06-11

Publications (1)

Publication Number Publication Date
PL372202A1 true PL372202A1 (pl) 2005-07-11

Family

ID=29724385

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03372202A PL372202A1 (pl) 2002-06-11 2003-06-10 Zmodyfikowana briodyna 1 o obniżonej immunogeniczności

Country Status (13)

Country Link
US (1) US20060019885A1 (pl)
EP (1) EP1511519A1 (pl)
JP (1) JP2005535304A (pl)
KR (1) KR20050010898A (pl)
CN (1) CN1658905A (pl)
AU (1) AU2003274705A1 (pl)
BR (1) BR0311308A (pl)
CA (1) CA2489153A1 (pl)
MX (1) MXPA04012210A (pl)
PL (1) PL372202A1 (pl)
RU (1) RU2004139047A (pl)
WO (1) WO2003103715A1 (pl)
ZA (1) ZA200500219B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06010716A (es) * 2004-03-19 2007-02-21 Merck Patent Gmbh Proteinas bouganin modificadas, citotoxinas y metodos y usos de las mismas.
US9065595B2 (en) 2005-04-07 2015-06-23 Opanga Networks, Inc. System and method for peak flow detection in a communication network
US11258531B2 (en) 2005-04-07 2022-02-22 Opanga Networks, Inc. System and method for peak flow detection in a communication network
KR20080033383A (ko) * 2005-08-12 2008-04-16 아스트라제네카 아베 방법
TW200848039A (en) * 2007-02-09 2008-12-16 Astrazeneca Ab Pharmaceutical compositions
US9388397B2 (en) 2013-02-15 2016-07-12 Research Development Foundation Deimmunized gelonin molecules and therapies
US20240145028A1 (en) * 2022-10-26 2024-05-02 Deargen Inc. Method For Data Augmentation Related To Target Protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541110A (en) * 1994-05-17 1996-07-30 Bristol-Myers Squibb Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica
DE69833755T2 (de) * 1997-05-21 2006-12-28 Biovation Ltd. Verfahren zur herstellung von nicht-immunogenen proteinen
AU776910B2 (en) * 1998-12-08 2004-09-23 Merck Patent Gesellschaft Mit Beschrankter Haftung Modifying protein immunogenicity
WO2002069232A2 (en) * 2001-02-19 2002-09-06 Merck Patent Gmbh Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity

Also Published As

Publication number Publication date
EP1511519A1 (en) 2005-03-09
KR20050010898A (ko) 2005-01-28
AU2003274705A1 (en) 2003-12-22
ZA200500219B (en) 2005-10-27
US20060019885A1 (en) 2006-01-26
CA2489153A1 (en) 2003-12-18
BR0311308A (pt) 2005-02-15
RU2004139047A (ru) 2006-01-20
MXPA04012210A (es) 2005-02-25
WO2003103715A1 (en) 2003-12-18
JP2005535304A (ja) 2005-11-24
CN1658905A (zh) 2005-08-24

Similar Documents

Publication Publication Date Title
SI1555267T1 (sl) 2,3-DIHIDRO-6-NITROIMIDAZO(2,1-b)OKSAZOLI
GB0118651D0 (en) Flat-plate
PL376950A1 (pl) Immunogenna kompozycja
GB0309138D0 (en) Design 2
GB0220501D0 (en) Push 22
PL372202A1 (pl) Zmodyfikowana briodyna 1 o obniżonej immunogeniczności
GB0208414D0 (en) The overlock
HUP0303523A3 (en) Modified insulin with reduced immunogenicity
GB2386580B (en) The bricky's mate
GB0202011D0 (en) The Fucker
GB0230156D0 (en) Sunscreens
GB0309136D0 (en) Design 1
GB0206835D0 (en) Iv 2
GB0209835D0 (en) Easy 1
GB0212233D0 (en) The chair pinnie
GB0203312D0 (en) 8323610001
GB0205625D0 (en) Lazline 3000
GB0212244D0 (en) AM 2000 Sleep-alert
GB0302925D0 (en) 4P re use 001
GB0216172D0 (en) Text 3
GB0228029D0 (en) The "wand"
GB0222241D0 (en) TSPGolf - putter#001
GB0218474D0 (en) The Quitter
GB0223702D0 (en) The rarefier
GB0228026D0 (en) The tippal

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)